ArticleZeitschrift fur Rheumatologie2026

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Kai Wai Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.